Abstract
A review is presented on quantitative structure-activity relationships (QSARs) of renin inhibitors which have potential as antihypertensive and cardiovascular agents. They inhibit the renin, an enzyme that is involved in the rate-limiting first step of the renin angiotensin system (RAS). Most of the renin inhibitors are peptidomimetics but recently some nonpeptidomimetic renin inhibitors with low molecular weight have also been developed. In both types of renin inhibitors, the QSARs have exhibited that their inhibition activity would largely depend upon the molecular weight of the compounds, van der waals radius related parameters of the substituents, and the localized electronic effects, particularly of the side chain of the residues substituted in the peptides.
Keywords: renin inhibitors, aspartic protease inhibitors, antihypertensive agents, pepstatin analogues, quantitative structureactivity relationships
Mini-Reviews in Medicinal Chemistry
Title: Quantitative Structure-Activity Relationships of Renin Inhibitors
Volume: 3 Issue: 4
Author(s): Satya P. Gupta
Affiliation:
Keywords: renin inhibitors, aspartic protease inhibitors, antihypertensive agents, pepstatin analogues, quantitative structureactivity relationships
Abstract: A review is presented on quantitative structure-activity relationships (QSARs) of renin inhibitors which have potential as antihypertensive and cardiovascular agents. They inhibit the renin, an enzyme that is involved in the rate-limiting first step of the renin angiotensin system (RAS). Most of the renin inhibitors are peptidomimetics but recently some nonpeptidomimetic renin inhibitors with low molecular weight have also been developed. In both types of renin inhibitors, the QSARs have exhibited that their inhibition activity would largely depend upon the molecular weight of the compounds, van der waals radius related parameters of the substituents, and the localized electronic effects, particularly of the side chain of the residues substituted in the peptides.
Export Options
About this article
Cite this article as:
Gupta P. Satya, Quantitative Structure-Activity Relationships of Renin Inhibitors, Mini-Reviews in Medicinal Chemistry 2003; 3 (4) . https://dx.doi.org/10.2174/1389557033488051
DOI https://dx.doi.org/10.2174/1389557033488051 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Burden of Metabolic Diseases Amongst HIV Positive Patients on HAART Attending the Johannesburg Hospital
Current HIV Research Regulation of Blood Flow by Prostaglandins
Current Vascular Pharmacology Current Tools and Methods in Molecular Dynamics (MD) Simulations for Drug Design
Current Medicinal Chemistry Renin Angiotensin System as a Regulator of Cell Volume. Implications to Myocardial Ischemia
Current Cardiology Reviews Role of Wnt Signaling in Tissue Fibrosis, Lessons from Skeletal Muscle and Kidney
Current Molecular Medicine Older Adults with Amnestic Mild Cognitive Impairment Exhibit Exacerbated Gait Slowing under Dual-Task Challenges
Current Alzheimer Research HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Current Pharmaceutical Design Pharmacological Management of No Reflow During Percutaneous Coronary Intervention
Current Vascular Pharmacology Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...
Current Pharmaceutical Design Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters
Current Drug Metabolism Advances in Adjuvant Therapy Against Acute Bacterial Meningitis
Current Drug Targets - Infectious Disorders Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Current Vascular Pharmacology Can Anthropometric and Body Composition Measurements During Pregnancy be Used to Predict Preeclampsia Risk?
Current Women`s Health Reviews Angelica Injection Reduces Cognitive Impairment during Chronic Cerebral Hypoperfusion through Brain-Derived Neurotrophic Factor and Nerve Growth Factor
Current Neurovascular Research Role of the heme oxygenase-adiponectin-atrial natriuretic peptide axis in renal function
Current Pharmaceutical Design Radicals, Oxidative/Nitrosative Stress and Preeclampsia
Mini-Reviews in Medicinal Chemistry Relation Between Obstructive Sleep Apnea Syndrome and Resistant Hypertension - The Tip of the Iceberg
Current Respiratory Medicine Reviews Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging